Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Cheever

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1994
Donor T cells can be induced to grow and survive long term in vivo without previous host immunosuppressionW Chen, M A Cheever
Immunological Reviews|June 1, 1997
Therapy with cultured T cells: principles revisitedM A Cheever, W Chen
Advances in Cancer Research|January 1, 1997
HER-2/neu protein: a target for antigen-specific immunotherapy of human cancerM L Disis, M A Cheever
Journal of Biological Response Modifiers|October 1, 1984
Effector mechanisms operative in adoptive therapy of tumor-bearing animals: implications for the use of interleukin-2P D Greenberg, M A Cheever
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1984
Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cellsP D Greenberg, M A Cheever
The Journal of Experimental Medicine|January 1, 1989
Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemiaD J Peace, M A Cheever
Critical Reviews in Immunology|January 7, 1998
HER-2/neu oncogenic protein: issues in vaccine developmentM L Disis, M A Cheever
Survey of Immunologic Research|January 1, 1985
Treatment of established tumor by adoptive immunotherapy with specifically immune T cellsP D Greenberg, M A Cheever
Contemporary Topics in Molecular Immunology|January 1, 1985
In vivo administration of interleukin-2M A Cheever, P D Greenberg
Current Opinion in Immunology|October 1, 1996
Oncogenic proteins as tumor antigensM L Disis, M A Cheever
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1994
Donor T cells can be induced to grow and survive long term in vivo without previous host immunosuppressionW Chen, M A Cheever
Immunological Reviews|June 1, 1997
Therapy with cultured T cells: principles revisitedM A Cheever, W Chen
Advances in Cancer Research|January 1, 1997
HER-2/neu protein: a target for antigen-specific immunotherapy of human cancerM L Disis, M A Cheever
Journal of Biological Response Modifiers|October 1, 1984
Effector mechanisms operative in adoptive therapy of tumor-bearing animals: implications for the use of interleukin-2P D Greenberg, M A Cheever
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1984
Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cellsP D Greenberg, M A Cheever
The Journal of Experimental Medicine|January 1, 1989
Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemiaD J Peace, M A Cheever
Critical Reviews in Immunology|January 7, 1998
HER-2/neu oncogenic protein: issues in vaccine developmentM L Disis, M A Cheever
Survey of Immunologic Research|January 1, 1985
Treatment of established tumor by adoptive immunotherapy with specifically immune T cellsP D Greenberg, M A Cheever
Contemporary Topics in Molecular Immunology|January 1, 1985
In vivo administration of interleukin-2M A Cheever, P D Greenberg
Current Opinion in Immunology|October 1, 1996
Oncogenic proteins as tumor antigensM L Disis, M A Cheever
Pageof 11